# Junta clínica — PT-pseudo_2eef4115a253 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_2eef4115a253",
  "pid": "PT-pseudo_2eef4115a253",
  "task": 1,
  "psa": 2.11,
  "age": 59,
  "months": 1,
  "pirads": "4",
  "psad": 0.058,
  "psav": -0.04,
  "psap": 2.1,
  "vol": 36.08,
  "dre": "Normal",
  "bx": "None",
  "cspca": 0.7737494,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 2.11 ng/mL. PI-RADS 4. PSAD 0.06. Prostate volume 36 mL. csPCa 0.77.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "85 kg",
    "height": "182 cm",
    "bmi": "25.7",
    "bp": "117/84 mmHg",
    "hr": "73 bpm",
    "smoking": "Ex-smoker (36 pack-yr, quit 2021)",
    "last_dental": "3 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "01 Feb 2025",
  "enc_ref": "Dr. E. Mulder (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Evaluation requested after imaging revealed a left peripheral zone abnormality alongside a recent PSA elevation."
    },
    {
      "s": "History",
      "t": "At 59 years of age, the patient works as a retired shopkeeper. He is divorced and currently resides with his partner. A former smoker, he accumulated 36 pack-years before cessation in 2021. Daily activity remains largely sedentary, punctuated by brief walks. Moderate voiding complaints dominate the history, specifically nocturia and a diminished urinary stream, correlating with an IPSS score of 19. He explicitly denies haematuria or pelvic discomfort. No chronic comorbidities exist, and he takes no active medications. Alcohol intake averages two units per week. An Arabic interpreter will be required during the consultation to facilitate precise dialogue."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: symmetrically smooth; consistency: normal; asymmetry: absent; nodules: none. Vital parameters remain stable, recording a blood pressure of 117/84 mmHg alongside a regular heart rate of 73 bpm. Thoracic auscultation reveals clear lung fields, and no peripheral oedema is observed."
    }
  ],
  "occupation": "retired shopkeeper",
  "marital": "Divorced",
  "living": "Lives with partner",
  "next_of_kin": "Sibling (sister)",
  "recent_other": [
    "Dermatology — actinic keratosis check",
    "Pulmonary function test — known COPD follow-up",
    "Vascular surgery — varicose veins consult"
  ],
  "alcohol": "2 units / week",
  "exercise": "Sedentary lifestyle, occasional walking",
  "ipss": "IPSS score: 19/35 (moderate LUTS)",
  "admin": "Interpreter (Arabic) requested for next visit.",
  "mri_hospital": "Radboudumc",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_2eef4115a253
Task: 1

Encounter: Urology - outpatient on 01 Feb 2025.
Referrer: Dr. E. Mulder (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 59-year-old male
  - PSA: 2.11 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.058 ng/mL²
  - PSA velocity: -0.04 ng/mL/yr
  - Prior PSA: 2.1 ng/mL
  - Prostate volume: 36.08 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.7737494 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 2.11 ng/mL. PI-RADS 4. PSAD 0.06. Prostate volume 36 mL. csPCa 0.77.

Vitals: weight 85 kg, height 182 cm, BMI 25.7, BP 117/84 mmHg, HR 73 bpm. Smoking: Ex-smoker (36 pack-yr, quit 2021).

Chief complaint: Evaluation requested after imaging revealed a left peripheral zone abnormality alongside a recent PSA elevation.

History: At 59 years of age, the patient works as a retired shopkeeper. He is divorced and currently resides with his partner. A former smoker, he accumulated 36 pack-years before cessation in 2021. Daily activity remains largely sedentary, punctuated by brief walks. Moderate voiding complaints dominate the history, specifically nocturia and a diminished urinary stream, correlating with an IPSS score of 19. He explicitly denies haematuria or pelvic discomfort. No chronic comorbidities exist, and he takes no active medications. Alcohol intake averages two units per week. An Arabic interpreter will be required during the consultation to facilitate precise dialogue.

Physical examination: DRE — texture: symmetrically smooth; consistency: normal; asymmetry: absent; nodules: none. Vital parameters remain stable, recording a blood pressure of 117/84 mmHg alongside a regular heart rate of 73 bpm. Thoracic auscultation reveals clear lung fields, and no peripheral oedema is observed.

Patient info: retired shopkeeper; Divorced; Lives with partner.
Next of kin: Sibling (sister).

Lifestyle: alcohol 2 units / week; exercise Sedentary lifestyle, occasional walking; IPSS score: 19/35 (moderate LUTS).

Recent other appointments: Dermatology — actinic keratosis check; Pulmonary function test — known COPD follow-up; Vascular surgery — varicose veins consult.
Admin: Interpreter (Arabic) requested for next visit.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.80
  uncertainty  +/- 0.10 epistemic (95% band 0.62-0.99); among patients I cannot tell apart the outcome was 0.71 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

What moved me most, across the labelled series: prior positive biopsy, PI-RADS >= 4, no prior biopsy, pmhx_hypercholesterolaemia, suspicious DRE, number of comorbidities. I read 39 variables, all
from the panel — nothing from the mpMRI prose, the PSA trajectory, the previous notes or the
laboratory. Out-of-fold over 91 labelled cases: AUC 0.758, balanced
accuracy 0.625.

The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 24 labelled men in this same situation (None prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.00 — IDENTICAL PANEL: this is the same case, already in the labelled series: PI-RADS 4, PSA 2.11, PSAD 0.058, age 59, DRE Normal -> BIOPSY (clear). He wrote: "P4 and LUTS symptoms. Note , low PSA."
  2. distance 1.79: PI-RADS NA, PSA 4.5, PSAD 0.095, age 67, DRE Normal -> DEFER (clear). He wrote: "Normal MRI. No biopsy"
  3. distance 2.12: PI-RADS 4, PSA 4.8, PSAD 0.086, age 65, DRE Nodus -> BIOPSY (clear). He wrote: "P4 in patient 65 years."

PRECEDENT: BIOPSY. The nearest precedent is this very patient, so the library returns what the reading urologist actually did with him. That is a record, not a judgement; out of sample this expert is worth only what the distance is worth.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. This patient is in the labelled series, so what follows is the reading urologist's own trace for him, not a prediction.

WHAT HE OPENS: radiology_report, previous_notes.
WHAT HE WEIGHS: dre=noted, psa=noted, pirads=decisive, vol=noted, psad=noted, age=important, bx=important, fh=noted.
HOW SURE HE USUALLY IS: clear.

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines link PI-RADS scores to the decision to biopsy, noting that a PI-RADS threshold of $\ge 3$ is used to trigger biopsy. The guideline also suggests that combining targeted biopsy with perilesional sampling when MRI is positive (i.e., PI-RADS $\ge 4$) can mitigate drawbacks.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
Expert 1's suggestion of biopsy is not definitively settled by the guideline because the guideline provides a threshold ($\ge 3$) but does not dictate the action for a specific PI-RADS 4 finding in isolation. Expert-Cohort's criterion, which matches the reading urologist in 24/24 cases for PI-RADS $\ge 3$, is a procedural rule, but the guideline does not mandate that specific action for this patient.

WHAT WE STILL NEED
The guideline requires establishing the PSA density value to determine if it falls below the $0.15 \text{ ng/mL/cc}$ cut-off, as this is a significant predictor in the risk-adapted matrix.
The prior-biopsy status is known as "None," which is a factor in the cohort study regarding biopsy reduction.
The PI-RADS score is known as "4," which is the primary factor triggering the guideline's threshold.
The PSA density is known as $0.058 \text{ ng/mL/cc}$, which is below the $0.15 \text{ ng/mL/cc}$ cut-off.
The previous notes state "Prior biopsy: None," which is a factor in the cohort study regarding biopsy reduction.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case strongly suggests biopsy based on the expert consensus, but we must first establish the required PSA density context according to the EAU guidelines.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> What is the lesion size and zone of the left peripheral zone abnormality?
  previous_notes (get_previous_notes) -> What is the management context regarding the prior biopsy status, number of sessions, and planned treatment?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. Given the PI-RADS 4 finding and the prior-biopsy status of 'None', what is the definitive management pathway according to the EAU guidelines?

On the plan itself: Dropped 1 question(s) that asked for a value already printed on the panel: "What is the PSA density value to determine if it falls below the $0.15 ext{ ng/mL/cc}$ cut-off?".

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The lesion size and zone of the left peripheral zone abnormality is: "A roughly 12 mm focal hypointense area occupies the left peripheral zone at mid-gland level."
previous_notes
The management context regarding the prior biopsy status, number of sessions, and planned treatment is: "Prior biopsy: None"

WHAT I DID NOT OPEN
I did not open the laboratory_results or the family-history anamnesis because the required information (PSA density and family history) was already explicitly stated in the structured panel or the previous notes.

WHAT THIS SUPPORTS
FOR sampling this patient now:
PI-RADS score of "4" as per the mpMRI report.
PSA density of "$0.058 \text{ ng/mL/cc}$".

AGAINST sampling this patient now:
Prior-biopsy status is "None".

WHERE THIS LEANS
The findings strongly support a biopsy due to the PI-RADS 4 finding and the PSA density, aligning with the expert consensus.
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

The serial PSA was not opened in this session, so I have no trajectory to project. I say nothing rather than project a headline value.

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.80
  uncertainty  +/- 0.08 epistemic (95% band 0.64-0.95), of which 0.00 comes from values that had to be imputed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

What moved me most across the labelled series: prior positive biopsy, no prior biopsy, free PSA < 15%, DWI restriction in the report, lesion >= 15 mm in the report, suspicious DRE. Out-of-fold AUC 0.794. I am the only expert that has read the report's wording, and I still cannot see the prior grade or the
surveillance history: those are in the notes, and the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.80  ('firm' tier)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.80  ('firm' tier, fusion_nolab)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=0.97  (identical panel in the series)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: identical precedent in the labelled series — carried by EXPERT-LIBRARY.
PANEL ANSWER: BIOPSY. The labelled series contains this exact panel; the library returns the reading urologist's own decision for it. Out of sample this rung never fires.

Confidence the trace model expects here: clear. Weights it expects: dre=noted, psa=noted, pirads=decisive, vol=noted, psad=noted, age=important, bx=important, fh=noted.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents opened, the radiology report and previous notes, directly address the moderator's questions by providing the lesion size and zone, and the prior biopsy status.

ALIGNMENT WITH THE PANEL
The retrieved evidence, specifically the PI-RADS 4 score and the prior biopsy status of 'None', aligns with the PANEL-PROTOCOL's decision to BIOPSY, which was driven by the EXPERT-LIBRARY precedent.

THE OPEN QUESTIONS, ONE BY ONE
Q1. Given the PI-RADS 4 finding and the prior-biopsy status of 'None', what is the definitive management pathway according to the EAU guidelines? The EAU guideline suggests a PI-RADS $\ge 3$ triggers biopsy, and the known prior-biopsy status is a factor in risk-adapted matrices.

WHAT CARRIES WEIGHT, AND WHY
The PI-RADS score of 4 is the primary driver, as it meets the EAU threshold for biopsy. The prior-biopsy status of 'None' is also a significant factor noted by the cohort criterion and expert consensus.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy, as the retrieved data strongly supports this action based on the PI-RADS score and the established expert consensus.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

Biopsy is recommended because the PI-RADS score of 4 meets the threshold for sampling according to EAU guidelines, and the prior-biopsy status of 'None' is a factor supporting this action. The decision was strongly supported by the expert consensus, which was solidified by the panel protocol citing an identical precedent in the labelled series. The evidence converged on proceeding with a biopsy based on the high-risk imaging finding.

What carried weight: psa=noted, pirads=decisive, vol=noted, psad=noted, age=important, bx=important
Documents this conference opened: radiology_report, previous_notes
